Living with Metastatic Breast Cancer

Share

Metastatic breast cancer (mBC) is breast cancer that has spread beyond the breast and nearby lymph nodes to other parts of the body, such as the bones, liver, lungs or brain. It is also known as Stage IV breast cancer.

While metastatic breast cancer is not currently curable, treatment continues to improve. New targeted therapies and advances in research are helping more people live with mBC as a manageable chronic condition.

At Breast Cancer Canada, we believe progress starts with research. And continues with access.

Research that brings us more options.

Across Canada, researchers are working to better understand metastatic breast cancer and find new ways to detect changes earlier, personalize treatment and improve outcomes.

This includes research in artificial intelligence, medical imaging, biomarkers, genomics and precision medicine.

At the University of Toronto, Dr. April Khademi is using artificial intelligence to study complex medical imaging data. Her work aims to better understand how cancer behaves and help guide more personalized treatment.

At Princess Margaret Cancer Centre, Dr. David Cescon is studying circulating tumour DNA and other molecular biomarkers. This research may help identify signs that a cancer is becoming resistant to therapy before those changes can be seen on an imaging scan.

At the Breast Cancer Canada Translational Research Unit at London Health Sciences, Dr. Alison Allan and her team are focused on understanding, tracking and treating metastatic breast cancer, with a focus on precision medicine. In 2026, Breast Cancer Canada and its donors are supporting nine new research awards at the BCC-TRU, focused on accelerating progress in metastatic breast cancer research.

Making clinical trials more accessible.

Research only changes care when patients can access it.

Clinical trials give people living with metastatic breast cancer an opportunity to access new treatments and contribute to research that can shape the future of care.

Breast Cancer Canada is supporting efforts to expand access to clinical trials, including through the Programme Accès-recherche Dr. André-Robidoux and the McPeak-Sirois Group in. This work focuses on improving access for people living with metastatic breast cancer, particularly through community hospitals and in rural and underserved communities.

As Kimberly Carson, CEO of Breast Cancer Canada, explains:

“Donor support directly connects more Canadians living with metastatic breast cancer to world-class, cutting-edge clinical trials. For people living with mBC, access to new treatments and clinical research can be especially important as they navigate ongoing treatment.”

Progress is possible

For people living with metastatic breast cancer, progress can mean more treatment options, better information about how a cancer is changing and greater access to clinical research.

It means investing in the science that can lead to better, more personalized care.

And it means making sure that where someone lives does not determine whether they can access treatment or participate in a clinical trial.

Breast Cancer Canada is working across the country to advance scientific breakthroughs, extend survival and drive precision research for people living with metastatic breast cancer.

Progress starts with research. Progress moves forward together.

Related Articles

Meet the Researcher: Modeline Longjohn

Dr. Modeline Longjohn is a postdoctoral fellow in the Department of Anatomy & Cell Biology atWestern University. She is conducting BCC-funded breast cancer research under

Metastatic Breast Cancer: ESMO 2026

Metastatic Breast Cancer (MBC) dominated much of the conversation at ESMO 2026, and for good reason. As treatment landscapes expand and different types of breast

Progress Through Research

Latest Research

Breast Cancer Canada donations fund life-saving research that directly impacts Canadian patients. That means better answers, bigger breakthroughs – and more personalized treatment for every breast cancer diagnosis.

Patient Tools

Our suite of digital tools are each designed to help individuals better manage their breast cancer journey through education, research and personalized insights, while also elevating the patient voice.

Patient Stories

Every breast cancer journey is unique, but together, these stories paint a powerful picture of progress. Through firsthand accounts from patients and survivors, we share stories that highlight the lived-experiences of breast cancer.

Fuel Progress

Progress happens when we invest in it. Canada is home to some of the world’s brightest minds in research. Together, we are advancing science, ensuring it leads to earlier detection, better treatments, and improved outcomes for patients across the country.

Sign Up, Know More